Dr Andia Redpath
Research groups
Collaborators
Andia Redpath
BSc, MRes, PhD
Postdoctoral Research Associate
Epicardial biology and cardiac regeneration
Dr Andia Redpath completed her BSc Biochemistry degree at Imperial College London in 2010. Dr Redpath continued her higher education at Imperial College London and was awarded an MRes (2011) and PhD degree (2015) in Biomedical Sciences Research. Dr Redpath specialised in bone marrow stem cells, osteoimmunology and regenerative pharmacology during this period. In 2016, Dr Redpath joined the Smart Group in DPAG and is currently investigating epicardial biology in cardiac development and post-injury. Dr Redpath is exploring HS-proteoglycan modifying enzymes and modulation of HSPG-dependent pathways in the epicardium.
Recent publications
-
Thymosin β4 protects against aortic aneurysm via endocytic regulation of growth factor signaling.
Journal article
Munshaw S. et al, (2021), J Clin Invest
-
Analysis of epicardial genes in embryonic mouse hearts with flow cytometry
Journal article
REDPATH A. et al, (2021), STAR Protocols, 2
-
Recapturing embryonic potential in the adult epicardium: Prospects for cardiac repair.
Journal article
Redpath AN. and Smart N., (2020), Stem Cells Transl Med
-
Biodegradable zinc-containing mesoporous silica nanoparticles for cancer therapy
Journal article
Chen S. et al, (2020), Materials Today Advances, 6
-
Spatiotemporal Analysis Reveals Overlap of Key Proepicardial Markers in the Developing Murine Heart.
Journal article
Lupu I-E. et al, (2020), Stem Cell Reports, 14, 770 - 787